Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biologic Classification of Adenocarinoma of the Esophagus and Esophagogastric Junction (AEG) Using a Novel Data-driven System: Should it Replace or Compliment the Siewert Classification?

NCT04151524 is registered in ClinicalTrials.gov with St. James's Hospital, Ireland as lead sponsor.

NCT NCT04151524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04151524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biologic Classification of Adenocarinoma of the Esophagus and Esophagogastric Junction (AEG) Using a Novel Data-driven System: Should it Replace or Compliment the Siewert Classification?
Lead sponsor
St. James's Hospital, Ireland
Phase
Observational
Overall status
Unknown status
Start date
October 23, 2019
Completion date
February 1, 2020
Enrollment
1,658 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

barrett esophagus, oesophagus cancer, siewert type i adenocarcinoma of esophagogastric junction, siewert type ii adenocarcinoma of esophagogastric junction, siewert type iii adenocarcinoma of esophagogastric junction